SK Bioscience breaks ground on vaccine plant expansion
By Chon, Seung-Hyun | translator Kim, Jung-Ju
24.03.07 11:51:42
가나다라
0
Expansion started on Andong L HOUSE…securing vaccine production plant for pneumococcal vaccine, a joint development with Sanofi
▲From the left, Dong-ho Oh, CEO of SK ecoengineering, Ki Chang Kwon, Mayor of Andong, Cheol-Woo Lee, Governor of Gyeongsangbuk-do, Jaeyong Ahn, CEO of SK bioscience, Pascal Robin, General Manager and Representative Director of Vaccines at Sanofi Korea, and other distinguished guests are commemorating a major expansion of Andong L HOUSE in South Korea.
SK Bioscience announced on the 7th that the company broke ground on a vaccine plant, ‘Andong L HOUSE,’ located in Andong, Gyeongsangbuk-do, South Korea. The plant will be expanded to install new equipment.
This expansion aims to increase vaccine production capacity for global supply by raising the existing vaccine plant within L House from one floor to three floors, securing a new space of approximately 4,200 ㎡.
SK Bioscience and global pharmaceutical company Sanofi have made a large-scale joint investment to expand this facility. The facility will be used to commercially produce the next-generation pneumococcal vaccine candidate product, called "GBP410." SK Bioscience and San
Chon, Seung-Hyun(1000@dailypharm.com)
If you want to see the full article, please JOIN US (click)